Hilton Head Health Launches GLP-1 Support Retreat as U.S. Weight-Loss Drug Use Reaches 11%
Updated
Updated · USA TODAY · Jul 20
Hilton Head Health Launches GLP-1 Support Retreat as U.S. Weight-Loss Drug Use Reaches 11%
3 articles · Updated · USA TODAY · Jul 20
Summary
Hilton Head Health is offering a GLP-1 Support program during select weeks, pairing introductory drug education with body-composition testing, biomarker screening, nutrition workshops, strength training and coaching.
11% of U.S. adults now take GLP-1 drugs for weight loss in 2026, up from 3% in 2024, driving demand for guidance before, during and after treatment.
Staff say the retreat does not push or discourage medications, instead focusing on habits that can improve long-term results, including protein, fluids, fiber and resistance exercise to limit muscle loss.
Many users regain weight after stopping GLP-1 drugs because appetite and "food noise" can return, so the program also emphasizes behavior change, body neutrality and practical plans guests can continue at home.
The offering taps into a broad obesity challenge: nearly 3 in 4 Americans over 19 are overweight, including just over 40% classified as obese.